1-7 of 7
Ying Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PLGA–Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo

Available to Purchase
Vinodh Kannappan, Ying Liu, Zhipeng Wang, Karim Azar, Sathishkumar Kurusamy, Rajagopal S. Kilari, Angel L. Armesilla, Mark R. Morris, Mohammad Najlah, Peng Liu, Xiu-Wu Bian, Weiguang Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (8): 1273–1284.
https://doi.org/10.1158/1535-7163.MCT-22-0066
Published: 02 August 2022
View article titled, PLGA–Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo
Open the PDF for PLGA–Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo in another window
Includes: Supplementary data
Journal Articles

Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Free
Tingyu Wu, Wei Chen, Yongwang Zhong, Xiaodan Hou, Shengyun Fang, Chen-Ying Liu, Guanghui Wang, Tong Yu, Yu-Yang Huang, Xuesong Ouyang, Henry Q.X. Li, Long Cui, Yili Yang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (4): 717–728.
https://doi.org/10.1158/1535-7163.MCT-16-0553
Published: 02 April 2017
View article titled, Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor
Open the PDF for Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor in another window
Includes: Supplementary data
Journal Articles

USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry

Free
Tieju Liu, Baocun Sun, Xiulan Zhao, Yanlei Li, Xueming Zhao, Ying Liu, Zhi Yao, Qiang Gu, Xueyi Dong, Bing Shao, Xian Lin, Fang Liu, Jindan An
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (9): 2121–2131.
https://doi.org/10.1158/1535-7163.MCT-15-0114-T
Published: 02 September 2015
View article titled, USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry
Open the PDF for USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry in another window
Includes: Supplementary data
Journal Articles

Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

Free
Lai-Ping Zhong, Dong-Wang Zhu, William N. William, Jr, Ying Liu, Jie Ma, Cheng-Zhe Yang, Xiao Yang, Li-Zhen Wang, Jiang Li, Jeffrey N. Myers, J. Jack Lee, Chen-Ping Zhang, Zhi-Yuan Zhang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 1112–1121.
https://doi.org/10.1158/1535-7163.MCT-12-1013
Published: 09 June 2013
View article titled, Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
Open the PDF for Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease in another window
Includes: Supplementary data
Journal Articles

Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway

Free
Kenneth Thress, Terry MacIntyre, Haiyun Wang, Dave Whitston, Zhong-Ying Liu, Ethan Hoffmann, Tao Wang, Jeffrey L. Brown, Kevin Webster, Charles Omer, Peter E. Zage, Lizhi Zeng, Patrick A. Zweidler-McKay
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (7): 1818–1827.
https://doi.org/10.1158/1535-7163.MCT-09-0036
Published: 14 July 2009
View article titled, Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway
Open the PDF for Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway in another window
Includes: Supplementary data
Journal Articles

N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing

Free
Hongtao Wang, Barry J. Maurer, Yong-Yu Liu, Elaine Wang, Jeremy C. Allegood, Samuel Kelly, Holly Symolon, Ying Liu, Alfred H. Merrill,, Jr., Valérie Gouazé-Andersson, Jing Yuan Yu, Armando E. Giuliano, Myles C. Cabot
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (9): 2967–2976.
https://doi.org/10.1158/1535-7163.MCT-08-0549
Published: 11 September 2008
View article titled, N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
Open the PDF for N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing in another window
Journal Articles

In vivo inhibition of tumor angiogenesis by systemic delivery of siRNA against VEGF pathway using TargeTran technology

Free
Frank Xie, Yijia Liu, Ying Liu, Puthupparampil Scaria, Martin Woodle, Qing Zhou, Xiaodong Yang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B150.
Published: 01 November 2007
View article titled, In vivo inhibition of tumor angiogenesis by systemic delivery of siRNA against VEGF pathway using TargeTran technology